AKR1C1 and cancer: Compared to TN and MPR patients, we observed that enzymes in the Aldo-Keto Reductase family (AKR1B1/10 and AKR1C1-3) were highly expressed in cancer cells from NMPR patients (Fig. 2D and Additional file 2: Fig. S4E-F).